Form D · Private Equity Fund
Drug Royalties Solutions Fund LLC
New York, NY · CIK 0001798418
Offering snapshot reported Jan 9, 2020 · SEC filing
- Reported sold
- $17.9M Indefinite offering
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 27, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 9, 2020 | Initial | $17,875,000 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357591
Source: Form D, filed Jan 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
DRUG ROYALTIES SOLUTIONS FUND LLC
Investment adviser: STONE RIDGE ASSET MANAGEMENT LLC
- Gross asset value
- $18.1M
- Beneficial owners
- 24
- ADV minimum commitment
- $100K
Reported in Form ADV on Jan 22, 2021. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
ERNST & YOUNG LLP
PCAOB 42
U.S. BANK NATIONAL ASSOCIATION
LEI 6BYL5QZYBDK8S7L73M02
Filing source
Form ADV 1484721 · Jan 22, 2021 · Schedule D 7.B.(1), fund 805-3905527115
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Thomas Rothwell | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022